Large-scale testing (Phase 3)Study completedNCT02038920What this trial is testingPhase III Study of MLN0002 (300 mg) in Treatment of Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 157
Large-scale testing (Phase 3)Study completedNCT00543374What this trial is testingExtended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's DiseaseWho this might be right forCrohn's Disease Mesoblast, Inc. 98
Not applicableStudy completedNCT00791557What this trial is testingOpen Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseaseWho this might be right forPyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more University Hospitals Cleveland Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT00265122What this trial is testingThe Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's DiseaseWho this might be right forCrohn Disease Centocor, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT00771667What this trial is testingSafety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF TherapyWho this might be right forCrohn's Disease Centocor, Inc. 526
Not applicableLooking for participantsNCT07034664What this trial is testingIUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective StudyWho this might be right forCrohn's DiseaseGuselkumabIntestinal Ultrasound+1 more The Third Xiangya Hospital of Central South University 50
Large-scale testing (Phase 3)UnknownNCT01817972What this trial is testingCimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's DiseaseWho this might be right forCrohn's Disease Gastroenterology Research of America 65